Disclaimer, Disclosures & Editorial Standards

Medical Disclaimer

WeightLossInjections.ca is an independent editorial publication. We are not a medical clinic, pharmacy, or healthcare provider. Nothing published on this website - including articles, guides, comparison tables, cost estimates, or sponsored content - constitutes medical advice, a clinical recommendation, or a substitute for professional medical consultation.

GLP-1 receptor agonists (including semaglutide, tirzepatide, and oral semaglutide) are prescription medications in Canada. They may only be obtained through a valid prescription issued by a licensed Canadian physician or nurse practitioner following a proper clinical assessment. Eligibility criteria, dosing, and appropriateness vary by individual.

Always consult a qualified healthcare professional before starting, stopping, or modifying any medication. If you experience adverse effects, contact your prescriber or call Health Link 811 (available in most provinces).

Province & Territory Availability

Online prescription services for GLP-1 medications through our affiliate partner Felix Health are currently available to residents of the following provinces:

Not currently available in: Quebec, Northwest Territories, Nunavut, and Yukon. Quebec residents and residents of Canadian territories should consult a local physician or clinic directly. Quebec operates under different telehealth and online pharmacy regulations (governed by the Collège des médecins du Québec and the Ordre des pharmaciens du Québec).

Affiliate & Sponsored Content Disclosure

WeightLossInjections.ca has an affiliate relationship with Felix Health, a licensed Canadian telehealth provider. When you click an affiliate link on this site and complete an assessment or purchase through Felix, we may receive a commission at no additional cost to you.

All sponsored and affiliate content is clearly labelled with disclosures such as "Sponsored · Felix Health" or "Sponsored Partner." Sponsored content does not influence our independent editorial coverage, cost estimates, clinical summaries, or comparisons.

We are not affiliated with, endorsed by, or compensated by Novo Nordisk (maker of Ozempic/Wegovy/Rybelsus), Eli Lilly (maker of Mounjaro), or any other pharmaceutical manufacturer.

Editorial Standards & Sources

Editorial content on WeightLossInjections.ca is produced by our independent editorial team. We aim to present accurate, up-to-date information drawn from authoritative sources including:

• Health Canada drug approvals and monographs
• Peer-reviewed clinical trials (SUSTAIN, STEP, SURMOUNT series)
• Provincial drug formularies (ODB, PharmaCare, RAMQ, Alberta Blue Cross, etc.)
• The New England Journal of Medicine, The Lancet, and other peer-reviewed journals
• Canadian Diabetes Care Guidelines
• Obesity Canada clinical practice guidelines

Despite our best efforts, drug coverage, pricing, and availability change frequently. Always verify current information with your pharmacist, provincial drug plan, or healthcare provider before making medical or financial decisions.

Regulatory Notice

All medications referenced on this site are regulated by Health Canada. Only medications approved by Health Canada may be legally prescribed and dispensed in Canada. Importation of prescription medications from other countries without Health Canada authorization is illegal and potentially dangerous.

Telehealth prescribers featured via our affiliate links are licensed by the appropriate provincial College of Physicians and Surgeons and are required to follow Canadian prescribing standards, including conducting a medically appropriate assessment before issuing any prescription.